ABT

SEC source: 0001415889-24-022826 · form4-09042024_100931.xml · nonDerivative · entry 1

MCCOY JOHN A. JR. · CIK 0001644207 · VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,708

SEC source: 0001415889-24-018920 · form4-07022024_080752.xml · nonDerivative · entry 2

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,143

SEC source: 0001415889-24-018885 · form4-07022024_080725.xml · derivative · entry 1

Alpern Robert J · CIK 0001448074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,754

Underlying: Common Shares · 75 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-018894 · form4-07022024_080707.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,509

Underlying: Common Shares · 317 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-018914 · form4-07022024_080740.xml · derivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,009

Underlying: Common Shares · 339 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-018916 · form4-07022024_080739.xml · derivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,895

Underlying: Common Shares · 353 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-018920 · form4-07022024_080752.xml · nonDerivative · entry 1

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,699

SEC source: 0001415889-24-013146 · form4-05142024_090502.xml · derivative · entry 7

Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Shares · 10,097 shares

Expires 2025-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001415889-24-013146 · form4-05142024_090502.xml · nonDerivative · entry 2

Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,341

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.55 to $104.62, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-24-013146 · form4-05142024_090502.xml · nonDerivative · entry 1

Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,438

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-012624 · form4-05082024_090550.xml · nonDerivative · entry 1

Earnhardt Lisa D · CIK 0001530893 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,462

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.08 to $106.39, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-24-011784 · form4-04302024_090408.xml · nonDerivative · entry 1

Alpern Robert J · CIK 0001448074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,163

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011786 · form4-04302024_090435.xml · nonDerivative · entry 1

Babineaux-Fontenot Claire · CIK 0001736637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,682

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011790 · form4-04302024_090442.xml · nonDerivative · entry 1

Blount Sally E. · CIK 0001537286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,023

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011791 · form4-04302024_090432.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,284

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011793 · form4-04302024_090408.xml · nonDerivative · entry 1

Kumbier Michelle · CIK 0001640036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,079

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011795 · form4-04302024_100436.xml · nonDerivative · entry 1

McDew Darren W · CIK 0001787479 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,757

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011796 · form4-04302024_100447.xml · derivative · entry 2

McKinstry Nancy · CIK 0001294731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,850

Underlying: Common Shares · 6,850 shares

Expires 2034-04-25

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001415889-24-011796 · form4-04302024_100447.xml · nonDerivative · entry 1

McKinstry Nancy · CIK 0001294731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,089

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011797 · form4-04302024_100452.xml · derivative · entry 2

O'Grady Michael · CIK 0001527742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,404

Underlying: Common Shares · 4,404 shares

Expires 2034-04-25

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001415889-24-011797 · form4-04302024_100452.xml · nonDerivative · entry 1

O'Grady Michael · CIK 0001527742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,682

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011799 · form4-04302024_100430.xml · nonDerivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,843

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011801 · form4-04302024_100404.xml · derivative · entry 3

STARKS DANIEL J · CIK 0000902132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,277

Underlying: Common Shares · 5,277 shares

Expires 2034-04-25

F3 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001415889-24-011801 · form4-04302024_100404.xml · nonDerivative · entry 1

STARKS DANIEL J · CIK 0000902132 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,727,182

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-011807 · form4-04302024_100450.xml · nonDerivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,398

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001415889-24-009860 · form4-04022024_100416.xml · derivative · entry 1

Alpern Robert J · CIK 0001448074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,628

Underlying: Common Shares · 69 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-009861 · form4-04022024_100413.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,174

Underlying: Common Shares · 290 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-009863 · form4-04022024_100413.xml · derivative · entry 1

Roman Michael F · CIK 0001577544 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,650

Underlying: Common Shares · 310 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-009864 · form4-04022024_100450.xml · derivative · entry 1

Stratton John G · CIK 0001385262 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,486

Underlying: Common Shares · 323 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001415889-24-006396 · form4-03042024_110352.xml · nonDerivative · entry 2

ALLEN HUBERT L · CIK 0001565916 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,806

SEC source: 0001415889-24-006405 · form4-03042024_110302.xml · nonDerivative · entry 2

Earnhardt Lisa D · CIK 0001530893 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,314

SEC source: 0001415889-24-006409 · form4-03052024_120333.xml · nonDerivative · entry 2

MCCOY JOHN A. JR. · CIK 0001644207 · VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,760

SEC source: 0001415889-24-006410 · form4-03052024_120338.xml · nonDerivative · entry 2

Moreland Mary K · CIK 0001783147 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,260

SEC source: 0001415889-24-006413 · form4-03052024_120313.xml · nonDerivative · entry 2

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,968

SEC source: 0001415889-24-006417 · form4-03052024_120350.xml · nonDerivative · entry 2

Salvadori Daniel Gesua Sive · CIK 0001620564 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,697

SEC source: 0001415889-24-006396 · form4-03042024_110352.xml · nonDerivative · entry 1

ALLEN HUBERT L · CIK 0001565916 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,659

SEC source: 0001415889-24-006402 · form4-03042024_110324.xml · nonDerivative · entry 1

Boudreau Philip P · CIK 0001805099 · SENIOR VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,353

SEC source: 0001415889-24-006405 · form4-03042024_110302.xml · nonDerivative · entry 1

Earnhardt Lisa D · CIK 0001530893 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,008

SEC source: 0001415889-24-006406 · form4-03042024_110304.xml · nonDerivative · entry 1

Ford Robert B · CIK 0001612571 · Director · CHAIRMAN AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,059

SEC source: 0001415889-24-006408 · form4-03052024_120326.xml · nonDerivative · entry 1

Funck, Jr. Robert E. · CIK 0001565892 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,341

SEC source: 0001415889-24-006409 · form4-03052024_120333.xml · nonDerivative · entry 1

MCCOY JOHN A. JR. · CIK 0001644207 · VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,232

SEC source: 0001415889-24-006410 · form4-03052024_120338.xml · nonDerivative · entry 1

Moreland Mary K · CIK 0001783147 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,936

SEC source: 0001415889-24-006413 · form4-03052024_120313.xml · nonDerivative · entry 1

Morrone Louis H. · CIK 0001867666 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,769

SEC source: 0001415889-24-006417 · form4-03052024_120350.xml · nonDerivative · entry 1

Salvadori Daniel Gesua Sive · CIK 0001620564 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,660

SEC source: 0001415889-24-006422 · form4-03052024_120352.xml · nonDerivative · entry 1

Wainer Andrea F · CIK 0001778070 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,365

SEC source: 0001415889-24-005576 · form4-02272024_110219.xml · derivative · entry 3

Wainer Andrea F · CIK 0001778070 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,449

Underlying: Common Shares · 12,500 shares

Expires 2028-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

SEC source: 0001415889-24-005576 · form4-02272024_110219.xml · nonDerivative · entry 2

Wainer Andrea F · CIK 0001778070 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,704

SEC source: 0001415889-24-005576 · form4-02272024_110219.xml · nonDerivative · entry 1

Wainer Andrea F · CIK 0001778070 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-24-005066 · form4-02232024_100225.xml · derivative · entry 2

ALLEN HUBERT L · CIK 0001565916 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,318

Underlying: Common Shares · 67,318 shares

Expires 2034-02-20

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 22,439 on February 21, 2025, 22,439 on February 21, 2026, and 22,440 on February 21, 2027.

SEC source: 0001415889-24-005066 · form4-02232024_100225.xml · nonDerivative · entry 1

ALLEN HUBERT L · CIK 0001565916 · EXECUTIVE VICE PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,873

F1 · shares: These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.